Preface to the Second Edition |
|
xv | |
Abbreviations |
|
xvii | |
Symbols and Units |
|
xxi | |
1 Introduction to Pharmaceutical Analytical Chemistry |
|
1 | (8) |
|
|
|
1.2 Pharmaceutical Analytical Chemistry |
|
|
4 | (3) |
|
|
4 | (1) |
|
1.2.2 Manufacture of Pharmaceuticals |
|
|
4 | (2) |
|
1.2.3 Development of New Drugs |
|
|
6 | (1) |
|
1.2.4 Use of Pharmaceuticals |
|
|
6 | (1) |
|
|
7 | (2) |
2 Marketing Authorizations, Pharmaceutical Manufacturing, and International Pharmacopoeias |
|
9 | (8) |
|
|
9 | (1) |
|
2.2 Marketing Authorization and Industrial Production |
|
|
10 | (3) |
|
|
13 | (1) |
|
2.4 Life Time of Pharmaceutical Preparations and Ingredients |
|
|
14 | (3) |
3 Fundamentals of Bases, Acids, Solubility, Polarity, Partition, and Stereochemistry |
|
17 | (20) |
|
3.1 Acids, Bases, pH, and pKa |
|
|
17 | (2) |
|
|
19 | (1) |
|
3.3 Acid and Base Properties of Drug Substances |
|
|
20 | (1) |
|
3.4 Distribution Between Phases |
|
|
21 | (5) |
|
|
26 | (2) |
|
3.6 Active Pharmaceutical Ingredients - A Few Examples |
|
|
28 | (6) |
|
3.6.1 Fluoxetine - A Basic and Lipophilic Drug |
|
|
28 | (1) |
|
3.6.2 Atenolol - A More Polar Basic Drug |
|
|
29 | (1) |
|
3.6.3 Morphine - A Zwitterionic Drug (Base and Acid) |
|
|
30 | (1) |
|
3.6.4 Ibuprofen - An Acidic Drug |
|
|
31 | (2) |
|
3.6.5 Paracetamol - A Weak Acid |
|
|
33 | (1) |
|
3.6.6 Hydrocortisone - A Neutral Drug |
|
|
34 | (1) |
|
3.7 Stability of Drug Substances |
|
|
34 | (3) |
4 Fundamentals of Pharmaceutical Analytical Chemistry |
|
37 | (36) |
|
4.1 Pharmaceutical Analytical Chemistry |
|
|
37 | (2) |
|
4.2 How to Specify Quantities, Concentrations, and Compositions of Mixtures |
|
|
39 | (4) |
|
|
43 | (9) |
|
4.3.1 The Analytical Balance |
|
|
43 | (4) |
|
|
47 | (3) |
|
|
50 | (1) |
|
|
51 | (1) |
|
4.4 How to Make Solutions and Dilutions |
|
|
52 | (2) |
|
4.5 Errors, Accuracy, and Precision |
|
|
54 | (2) |
|
4.5.1 Systematic and Random Errors |
|
|
54 | (1) |
|
4.5.2 Accuracy and Precision |
|
|
55 | (1) |
|
|
56 | (9) |
|
4.6.1 Mean Value and Standard Deviation |
|
|
56 | (2) |
|
4.6.2 Confidence Intervals |
|
|
58 | (1) |
|
4.6.3 Comparison of Standard Deviations with the F-Test |
|
|
58 | (2) |
|
4.6.4 Comparison of Means with a t-Test |
|
|
60 | (4) |
|
4.6.5 Q-Test to Reject Outliers |
|
|
64 | (1) |
|
4.7 Linear Regression Analysis |
|
|
65 | (3) |
|
4.8 How to Present an Analytical Result |
|
|
68 | (2) |
|
4.9 Additional Words and Terms |
|
|
70 | (3) |
5 Titration |
|
73 | (24) |
|
|
73 | (6) |
|
5.2 Potentiometric Titration and Electrodes |
|
|
79 | (3) |
|
5.3 Aqueous Acid-Base Titrations |
|
|
82 | (6) |
|
5.4 Titration in Non-aqueous Solvents |
|
|
88 | (3) |
|
|
91 | (4) |
|
5.6 Alternative Principles of Titration |
|
|
95 | (2) |
6 Introduction to Spectroscopic Methods |
|
97 | (8) |
|
6.1 Electromagnetic Radiation |
|
|
97 | (2) |
|
6.2 Molecules and Absorption of Electromagnetic Radiation |
|
|
99 | (2) |
|
6.3 Absorbing Structures - Chromophores |
|
|
101 | (1) |
|
|
101 | (1) |
|
6.5 Atoms and Electromagnetic Radiation |
|
|
102 | (3) |
7 UV-Vis Spectrophotometry |
|
105 | (16) |
|
|
105 | (1) |
|
|
106 | (2) |
|
7.3 Absorbance Dependence on Measurement Conditions |
|
|
108 | (2) |
|
|
110 | (1) |
|
|
111 | (4) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
|
7.5.5 Single-Beam and Double-Beam Instruments |
|
|
114 | (1) |
|
7.6 Practical Work and Method Development |
|
|
115 | (1) |
|
7.7 Test of Spectrophotometers |
|
|
116 | (3) |
|
7.7.1 Control of Wavelengths |
|
|
117 | (1) |
|
7.7.2 Control of Absorbance |
|
|
117 | (1) |
|
7.7.3 Limit of Stray Light |
|
|
118 | (1) |
|
7.7.4 Resolution (for Qualitative Analysis) |
|
|
119 | (1) |
|
7.7.5 Spectral Slit-Width (for Quantitative Analysis) |
|
|
119 | (1) |
|
|
119 | (2) |
8 IR Spectrophotometry |
|
121 | (10) |
|
|
121 | (4) |
|
|
125 | (1) |
|
8.3 Recording by Transmission, Diffuse Reflectance, and Attenuated Total Reflection |
|
|
125 | (3) |
|
8.4 Instrument Calibration |
|
|
128 | (1) |
|
8.5 NIR Spectrophotometry |
|
|
129 | (2) |
9 Atomic Spectrometry |
|
131 | (12) |
|
9.1 Applications of Atomic Spectrometry |
|
|
131 | (1) |
|
9.2 Atomic Absorption Spectrometry (AAS) |
|
|
132 | (1) |
|
|
132 | (5) |
|
|
133 | (1) |
|
9.3.2 Sample Introduction System |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
9.3.5 Electrothermal Atomizer |
|
|
135 | (1) |
|
|
136 | (1) |
|
9.3.7 Background Correction |
|
|
137 | (1) |
|
9.4 AAS Practical Work and Method Development |
|
|
137 | (1) |
|
9.5 Atomic Emission Spectrometry (AES) |
|
|
138 | (1) |
|
|
139 | (1) |
|
9.7 Inductively Coupled Plasma Emission Spectrometry |
|
|
140 | (1) |
|
9.8 Inductively Coupled Plasma Mass Spectrometry |
|
|
141 | (2) |
10 Introduction to Chromatography |
|
143 | (16) |
|
|
143 | (1) |
|
|
144 | (2) |
|
|
146 | (3) |
|
|
149 | (2) |
|
|
151 | (1) |
|
|
152 | (2) |
|
|
154 | (1) |
|
10.8 The Dynamics of Chromatography |
|
|
155 | (4) |
11 Separation Principles in Liquid Chromatography |
|
159 | (26) |
|
|
159 | (1) |
|
11.2 Reversed-Phase Chromatography |
|
|
160 | (8) |
|
|
160 | (2) |
|
11.2.2 Retention Mechanisms |
|
|
162 | (2) |
|
|
164 | (4) |
|
11.3 Ion-Pair Chromatography |
|
|
168 | (2) |
|
11.4 Normal-Phase Chromatography |
|
|
170 | (3) |
|
11.4.1 Silica and Related Stationary Phases |
|
|
171 | (1) |
|
11.4.2 Molecular Interactions and Retention |
|
|
172 | (1) |
|
|
173 | (1) |
|
11.5 Thin-Layer Chromatography |
|
|
173 | (2) |
|
11.6 Hydrophilic Interaction Chromatography |
|
|
175 | (2) |
|
11.7 Ion Exchange Chromatography |
|
|
177 | (1) |
|
11.8 Size Exclusion Chromatography |
|
|
178 | (2) |
|
|
180 | (2) |
|
11.10 Supercritical Fluid Chromatography |
|
|
182 | (3) |
12 High Performance Liquid Chromatography |
|
185 | (14) |
|
|
185 | (1) |
|
|
186 | (2) |
|
12.3 Scaling Between Columns |
|
|
188 | (1) |
|
|
189 | (2) |
|
|
191 | (1) |
|
|
192 | (5) |
|
|
193 | (2) |
|
12.6.2 Fluorescence Detectors |
|
|
195 | (1) |
|
12.6.3 Electrochemical Detectors |
|
|
196 | (1) |
|
12.6.4 Refractive Index, Evaporative Light Scattering, and Charged Aerosol Detectors |
|
|
197 | (1) |
|
|
197 | (1) |
|
12.8 Solvents for Sample Preparation |
|
|
198 | (1) |
13 Gas Chromatography |
|
199 | (16) |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
201 | (2) |
|
|
203 | (2) |
|
|
205 | (2) |
|
|
207 | (1) |
|
|
208 | (1) |
|
|
209 | (2) |
|
|
211 | (2) |
|
|
213 | (2) |
14 Electrophoretic Methods |
|
215 | (16) |
|
|
215 | (1) |
|
14.2 Principle and Theory |
|
|
216 | (2) |
|
|
218 | (2) |
|
|
220 | (1) |
|
|
221 | (2) |
|
14.6 Isoelectric Focusing |
|
|
223 | (1) |
|
14.7 Capillary Electrophoresis |
|
|
223 | (8) |
|
14.7.1 Principle and Instrumentation |
|
|
223 | (1) |
|
14.7.2 Electro-osmotic Flow and Mobility |
|
|
224 | (2) |
|
|
226 | (2) |
|
|
228 | (1) |
|
14.7.5 Sample Introduction |
|
|
228 | (1) |
|
|
229 | (1) |
|
|
229 | (2) |
15 Mass Spectrometry |
|
231 | (28) |
|
|
231 | (2) |
|
15.2 Basic Theory of Mass Spectrometry |
|
|
233 | (2) |
|
|
235 | (1) |
|
15.4 The Mass Spectrometer as a Chromatographic Detector - Data Acquisition |
|
|
236 | (2) |
|
|
238 | (1) |
|
15.6 Identification by MS |
|
|
238 | (13) |
|
|
238 | (2) |
|
15.6.2 Structural Information from Isotopes |
|
|
240 | (2) |
|
15.6.3 Structural Information from Fragmentation |
|
|
242 | (5) |
|
15.6.4 Structural Information from Accurate Masses (High Resolution MS) |
|
|
247 | (2) |
|
15.6.5 Structural Information for Peptides and Proteins |
|
|
249 | (2) |
|
|
251 | (8) |
|
15.7.1 Ion Sources for GC-MS |
|
|
251 | (1) |
|
15.7.2 Ion Sources for LC-MS |
|
|
252 | (2) |
|
15.7.3 Single Quadrupole Analysers |
|
|
254 | (1) |
|
15.7.4 Triple Quadrupole Analysers |
|
|
255 | (1) |
|
15.7.5 Ion Trap Analysers |
|
|
256 | (1) |
|
15.7.6 Time-of-Flight Analysers |
|
|
257 | (1) |
|
15.7.7 High Resolution Instruments |
|
|
258 | (1) |
|
15.7.8 Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry |
|
|
258 | (1) |
16 Sample Preparation |
|
259 | (22) |
|
16.1 When is Sample Preparation Required? |
|
|
259 | (1) |
|
|
260 | (1) |
|
16.3 Recovery and Enrichment |
|
|
261 | (2) |
|
16.4 Liquid-Liquid Extraction |
|
|
263 | (6) |
|
|
263 | (1) |
|
|
264 | (1) |
|
16.4.3 Extraction Solvents |
|
|
265 | (2) |
|
16.4.4 Parameters Affecting Extraction Recovery |
|
|
267 | (2) |
|
16.4.5 Liquid-Liquid Extraction with Back-Extraction |
|
|
269 | (1) |
|
16.5 Solid-Liquid Extraction |
|
|
269 | (1) |
|
16.6 Solid Phase Extraction |
|
|
270 | (11) |
|
|
270 | (1) |
|
16.6.2 The Solid Phase Extraction Column |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
16.6.5 Reversed-Phase Solid Phase Extraction |
|
|
273 | (2) |
|
16.6.6 Secondary Interactions |
|
|
275 | (1) |
|
16.6.7 Ion Exchange Solid Phase Extraction |
|
|
275 | (3) |
|
16.6.8 Mixed-Mode Solid Phase Extraction |
|
|
278 | (1) |
|
16.6.9 Normal-Phase Solid Phase Extraction |
|
|
279 | (2) |
17 Quality of Analytical Data and Validation |
|
281 | (24) |
|
17.1 Instrumental Signals |
|
|
281 | (1) |
|
|
282 | (8) |
|
|
283 | (1) |
|
17.2.2 One Point Calibration |
|
|
284 | (1) |
|
|
285 | (3) |
|
|
288 | (1) |
|
|
289 | (1) |
|
17.3 Analytical Procedures |
|
|
290 | (1) |
|
|
291 | (10) |
|
|
292 | (1) |
|
|
293 | (1) |
|
|
294 | (1) |
|
|
295 | (2) |
|
17.4.5 Quantitation Limit |
|
|
297 | (1) |
|
17.4.6 Linearity and Range |
|
|
298 | (2) |
|
|
300 | (1) |
|
17.4.8 Test Methods in Ph. Eur. and USP |
|
|
300 | (1) |
|
|
301 | (4) |
|
17.5.1 Adjustment of Chromatographic Conditions |
|
|
301 | (4) |
18 Chemical Analysis of Pharmaceutical Ingredients |
|
305 | (84) |
|
18.1 Pharmaceutical Ingredients, Production, and Control |
|
|
306 | (2) |
|
18.2 Pharmacopoeia Monographs |
|
|
308 | (13) |
|
18.3 Impurities in Pharmaceutical Ingredients |
|
|
321 | (3) |
|
18.3.1 Impurities in Pure Chemical Ingredients |
|
|
321 | (3) |
|
18.3.2 Impurities in Organic Multi-Chemical Ingredients |
|
|
324 | (1) |
|
18.4 Identification of Pharmaceutical Ingredients |
|
|
324 | (20) |
|
18.4.1 IR Spectrophotometry |
|
|
324 | (6) |
|
18.4.2 UV-Vis Spectrophotometry |
|
|
330 | (3) |
|
18.4.3 Thin-Layer Chromatography |
|
|
333 | (1) |
|
|
334 | (1) |
|
|
335 | (5) |
|
18.4.6 Liquid Chromatography |
|
|
340 | (1) |
|
18.4.7 Chloride and Sulfate Identification |
|
|
341 | (3) |
|
18.5 Impurity Testing of Pharmaceutical Ingredients (Pure Chemical Ingredients) |
|
|
344 | (24) |
|
18.5.1 Appearance of Solution |
|
|
345 | (2) |
|
|
347 | (1) |
|
18.5.3 pH and Acidity or Alkalinity |
|
|
347 | (4) |
|
18.5.4 Related Substances |
|
|
351 | (4) |
|
|
355 | (4) |
|
|
359 | (2) |
|
|
361 | (2) |
|
18.5.8 Elemental Impurities |
|
|
363 | (3) |
|
|
366 | (1) |
|
|
367 | (1) |
|
18.6 Identification and Impurity Testing of Organic Multi-Chemical Ingredients |
|
|
368 | (7) |
|
18.6.1 Oxidizing Substances |
|
|
369 | (1) |
|
|
369 | (1) |
|
|
369 | (1) |
|
|
370 | (1) |
|
|
371 | (1) |
|
18.6.6 Saponification Value |
|
|
371 | (1) |
|
18.6.7 Unsaponifiable Matter |
|
|
372 | (1) |
|
|
372 | (3) |
|
18.7 Assay of Pharmaceutical Ingredients |
|
|
375 | (13) |
|
18.7.1 Aqueous Acid-Base Titration |
|
|
375 | (5) |
|
18.7.2 Non-Aqueous Acid-Base Titration |
|
|
380 | (3) |
|
|
383 | (2) |
|
18.7.4 Liquid Chromatography |
|
|
385 | (2) |
|
18.7.5 UV-Vis Spectrophotometry |
|
|
387 | (1) |
|
18.8 Chemical Analysis of Pharmaceutical Ingredients Not Included in Pharmacopoeias |
|
|
388 | (1) |
19 Chemical Analysis of Pharmaceutical Preparations |
|
389 | (44) |
|
19.1 Chemical Analysis of Pharmaceutical Preparations |
|
|
389 | (1) |
|
19.2 Monographs and Chemical Analysis |
|
|
390 | (5) |
|
19.3 Identification of the API |
|
|
395 | (15) |
|
19.3.1 Identification by IR Spectrophotometry |
|
|
396 | (5) |
|
19.3.2 Identification by Liquid Chromatography |
|
|
401 | (5) |
|
19.3.3 Identification by UV-Vis Spectrophotometry |
|
|
406 | (4) |
|
19.4 Assay of the Active Pharmaceutical Ingredient |
|
|
410 | (17) |
|
19.4.1 Assays Based on Liquid Chromatography |
|
|
411 | (8) |
|
19.4.2 Assays Based on UV Spectrophotometry |
|
|
419 | (4) |
|
19.4.3 Assays Based on Titration |
|
|
423 | (4) |
|
19.5 Chemical Tests for Pharmaceutical Preparations |
|
|
427 | (6) |
|
19.5.1 Test for Related Substances |
|
|
427 | (3) |
|
19.5.2 Uniformity of Content |
|
|
430 | (2) |
|
|
432 | (1) |
20 Bioanalysis Chemical Analysis of Pharmaceuticals in Biological Fluids |
|
433 | (26) |
|
|
433 | (5) |
|
|
434 | (1) |
|
20.1.2 Therapeutic Drug Monitoring |
|
|
435 | (1) |
|
20.1.3 Forensic and Toxicological Analysis |
|
|
436 | (1) |
|
20.1.4 Doping Control Analysis |
|
|
436 | (2) |
|
|
438 | (2) |
|
20.3 Bioanalytical Methods - An Overview |
|
|
440 | (1) |
|
|
440 | (1) |
|
|
441 | (5) |
|
20.5.1 Protein Precipitation |
|
|
441 | (2) |
|
20.5.2 Liquid-Liquid Extraction |
|
|
443 | (3) |
|
20.5.3 Solid-Phase Extraction |
|
|
446 | (1) |
|
20.6 Separation and Detection |
|
|
446 | (1) |
|
|
447 | (6) |
|
|
453 | (6) |
21 Chemical Analysis of Biopharmaceuticals |
|
459 | (46) |
|
|
459 | (4) |
|
21.1.1 Amino Acids, the Building Blocks of Biopharmaceuticals |
|
|
460 | (1) |
|
21.1.2 Structure of Proteins |
|
|
460 | (3) |
|
21.1.3 Glycosylation of Proteins and Peptides |
|
|
463 | (1) |
|
21.2 Biopharmaceuticals versus Small Molecule APIs |
|
|
463 | (1) |
|
21.3 Biopharmaceuticals and Pharmacopoeias |
|
|
464 | (1) |
|
21.4 Production of Biopharmaceuticals |
|
|
465 | (2) |
|
21.5 Identification Procedures for Biopharmaceuticals (Active Substance) |
|
|
467 | (21) |
|
21.5.1 Peptide Mapping - Information About Primary Structure |
|
|
468 | (8) |
|
21.5.2 Separation Techniques |
|
|
476 | (6) |
|
|
482 | (6) |
|
|
488 | (1) |
|
21.6 Impurity Tests for Biopharmaceuticals (Active Substances) |
|
|
488 | (10) |
|
21.6.1 Impurities with Differing Molecular Masses |
|
|
489 | (2) |
|
21.6.2 Impurities with Different Charges/Charge Variants |
|
|
491 | (4) |
|
21.6.3 Total Protein/Protein Content |
|
|
495 | (2) |
|
|
497 | (1) |
|
21.7 Assay of Biopharmaceuticals (Active Substance) |
|
|
498 | (2) |
|
21.8 Monoclonal Antibodies |
|
|
500 | (2) |
|
21.9 Analysis of Biopharmaceutical Products |
|
|
502 | (1) |
|
21.10 Bioanalysis of Biopharmaceuticals Using LC-MS/MS |
|
|
503 | (2) |
Index |
|
505 | |